Hypertension and diabetes in obesity

International Journal of Hypertension

Volumn 2011, Issue , 2011, Pages

  Masuo, Kazuko ^a,b   Tuck, Michael L ^c   Lambert, Gavin W ^a,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Nucleus Network Ltd   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL OBESITY; AMBULATORY CARE; ANTIHYPERTENSIVE THERAPY; ATHEROSCLEROSIS; BIRTH WEIGHT; BLOOD PRESSURE MONITORING; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; DIABETES MELLITUS; DIET; DISEASE ACTIVITY; DISEASE ASSOCIATION; DYSLIPIDEMIA; EDITORIAL; ETHNIC GROUP; ETHNICITY; EXERCISE; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HEART FUNCTION; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LIPID STORAGE; METABOLIC SYNDROME X; MULTIPLE ORGAN FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; SODIUM TRANSPORT; WEIGHT REDUCTION;

EID: 82155194860     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2011/695869     Document Type: Editorial

References (8)

1. Masuo K., Role of beta2- and beta33 adrenoceptor polymorphisms in hypertension and metabolic syndrome. International Journal of Hypertension 2010 2010 832821
2. Esler M. D., Straznicky N. E., Eikelis N., Masuo K., Lambert G., Lambert E. A., Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2008 48 787 796 2-s2.0-58949099728 10.1007/s11906-008-0083-1
3. Esler M., Jennings G., Lambert G., Noradrenaline release and the pathophysiology of primary human hypertension. American Journal of Hypertension 1989 2 3 1405 1465 2-s2.0-0024519641
4. Masuo K., Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin. Current Hypertension Reports 2002 4 2 112 118 2-s2.0-0036551287
5. Mokdad A. H., Ford E. S., Bowman B. A., Dietz W. H., Vinicor F., Bales V. S., Marks J. S., Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Journal of the American Medical Association 2003 289 1 76 79 2-s2.0-0037223174 10.1001/jama.289.1.76 (Pubitemid 36026281)
6. Barr E. L. M., Cameron A. J., Balkau B., Zimmet P. Z., Welborn T. A., Tonkin A. M., Shaw J. E., HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the australian diabetes, obesity and lifestyle study (AusDiab) study. Diabetologia 2010 53 1 79 88 2-s2.0-72449205432 10.1007/s00125-009-1588-0
7. Lambert E., Sari C. I., Dawood T., Nguyen J., McGrane M., Eikelis N., Chopra R., Wong C., Chatzivlastou K., Head G., Straznicky N., Esler M., Schlaich M., Lambert G., Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010 56 3 351 358 10.1161/HYPERTENSIONAHA.110.155663
8. Masuo K., Lambert G. W., Esler M. D., Rakugi H., Ogihara T., Schlaich M. P., The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertension Research 2010 33 6 521 528 2-s2.0-77953200567 10.1038/hr.2010.35